A potential rally to 6,000 is possible if retail sales are positive and the FOMC Meeting is dovish. Read why investors should ...
Sister Wives viewers were shocked to see Meri Brown during a recent live video and expressed concern for her sudden weight loss.
G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...
Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...
Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
VieMed, of a handful of publicly traded businesses in Lafayette, has reported double-digit increases in net revenue in each ...
Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Zealand ...
At the end of the month, policies that expanded Medicare coverage for telehealth during the pandemic will expire, unless ...
Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results